Recap: Aytu BioPharma Q4 Earnings

 

Aytu BioPharmaAYTU stock fell by 8.33% on Tuesday after the company reported its Q4 earnings results on Monday, September 27, 2021 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Aytu BioPharma missed their estimated earnings by 65.31%, which surprised analysts.

Revenue was up $8,621,000 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $-0.12, which was followed by a 3.21% drop in the share price the next day.

Here's a look at Aytu BioPharma's past performance and the resulting price change:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.49 -0.31 -0.44 -0.05 -0.03
EPS Actual -0.81 -0.43 -0.70 -0.04 -0.02
Price Change % -8.33% -3.21% -1.95% -5.9% -12.78%

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!